The quest for a herpes simplex virus vaccine: background and recent developments.

Area of Science:

• Virology
• Immunology
• Vaccinology

Background:

• Herpes simplex virus (HSV) causes a spectrum of human infections, from localized skin disease to life-threatening disseminated infections in immunocompromised individuals.
• Following initial infection, HSV establishes lifelong latency in sensory neurons, with potential for asymptomatic viral shedding or recurrent symptomatic episodes.
• Understanding HSV pathogenesis is crucial for developing effective therapeutic and preventative strategies.

Purpose of the Study:

• To review the immunological mechanisms underlying the human immune response to Herpes simplex virus (HSV) infections.
• To examine diverse vaccine development strategies aimed at preventing or controlling HSV-induced diseases.
• To provide an overview of the challenges and progress in combating HSV infections through vaccination.

Main Methods:

• Literature review of immunological mechanisms against HSV.
• Analysis of current and historical vaccine development approaches for HSV.
• Synthesis of information on viral latency and reactivation relevant to immune control.

Main Results:

• Detailed description of innate and adaptive immune responses crucial for controlling HSV.
• Identification of key viral factors and host immune evasion strategies.
• Overview of various vaccine platforms and their efficacy in preclinical and clinical studies.

Conclusions:

• The immune system employs complex mechanisms to control HSV, but viral latency poses a significant challenge.
• Developing an effective HSV vaccine remains difficult due to viral persistence and immune evasion.
• Continued research into immune responses and novel vaccine strategies is essential for controlling HSV infections.